Oxandrolone
Back to searchMolecule Structure
Scientific Name
Oxandrolone
Description of the Drug
Oxandrolone is an androgenic hormone used to treat muscle loss from prolonged corticosteroid treatment and to treat bone pain associated with osteoporosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00621
http://www.drugbank.ca/drugs/DB00621
Brand Name(s)
Anavar, Oxandrin, Oxandrolone
Company Owner(s)
Sandoz Inc, Par Pharmaceutical Inc, Upsher Smith Laboratories Llc, Roxane Laboratories Inc, Gemini Laboratories Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Androgen Receptor | SINGLE PROTEIN | AGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL148881 | |
| PharmGKB | PA164749395 | |
| Human Metabolome Database | HMDB0014759 | |
| DrugBank | DB00621 | |
| PubChem: Thomson Pharma | 14776396 | 14751988 |
| PubChem | 5878 | |
| LINCS | LSM-45444 | |
| Nikkaji | J1.367F | |
| EPA CompTox Dashboard | DTXSID8023399 | |
| DrugCentral | 2011 | |
| ChemicalBook | CB6112482 | |
| Guide to Pharmacology | 7092 | |
| rxnorm | OXANDROLONE | OXANDRIN |
| KEGG Ligand | C07346 | |
| ChEBI | 7820 | |
| ZINC | ZINC000003813047 |
